5 comments
43 forecasters
Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?
70%chance
4 points
No key factors yetAdd some that might influence this forecast.
Authors:
Opened:Nov 24, 2021
Closes:Jan 1, 2029
Scheduled resolution:Jan 1, 2029
Spot Scoring Time:Nov 26, 2021
